10:05 AM EST - Cipher Pharmaceuticals Inc. : Announced its financial and operating results for the three months ended June 30, 2019. Unless otherwise noted, all figures are in U.S. dollars. The company had $9.3 million in cash at June 30, 2019, compared to $7.9 million at March 31, 2019. Total revenue decreased to $5.6 million from $7.0 million. Net income from continuing operations of $1.4 million, or $0.05 per basic and diluted share ($0.066 in Canadian dollars), compared with net income from continuing operations of $1.9 million, or $0.07 per basic and diluted share. Cipher Pharmaceuticals Inc.
shares T.CPH are trading up $0.02 at $1.25.
